Wnt/pathway, APP processing and telomere shortening in Down syndrome adults

Abstract Background The Down Syndrome (DS), also referred to as trisomy of chromosome 21, is a prevalent cause of intellectual disability and also contributes to the acceleration of aging, among other developmental and health concerns. Certain pathological characteristics shared by DS and Alzheimer’s Disease (AD) indicate similar commonalities. This study aims to unravel the relationship between the canonical Wnt/pathway, the amyloid precursor protein processing, the telomere shortening in DS individuals. The telomere is a structure found at the end of the chromosomes that protects against degradation during cell division. The shortening of the telomere length is associated with the risk of AD. β‐catenin is an important factor in the canonical Wnt pathway. The activation of this pathway can protect against neurotoxic effects caused by accumulation of β‐amyloid peptide and the phosphorylation of Tau protein. The canonical Wnt activation is related with the activation of subunit Tert, also known as telomerase. Telomerase is an enzyme responsible for the maintenance of telomere length. Methods The biomarkers were quantified in the plasma and platelets of adults and elderly with DS (n = 55) and adults and elderly without DS (n = 80). We utilized western blot, for APP fragments (110 kDa and 130 kDa), Luminex xMAP, for AB40 fragment. The DNA was extracted from leukocytes and measured using qPCR method using 36B4 as single copy gene. Telomere length was calculated using the delta Ct value. Results We found increased levels of Aβ40 and in 110 kDa, 130 kDa APP fragments of Down syndrome individuals. β‐catenin was also increased in DS group when compared with non DS group. The telomere length was decrease in DS group when compared with non DS group. Conclusion The increase in Aβ40 and 110 kDa, 130 kDa fragments, demonstrated an imbalance in the APP processing, that could lead to the Aβ aggregation observed in DS individuals. The increase in the β‐catenin expression could be a compensatory mechanism for the telomere shortening in DS group.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092775
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Wnt/pathway, APP processing and telomere shortening in Down syndrome adults

Jessyka Maria de França Bram, Orestes Vicente Forlenza, Leda Leme Talib, Augusto Magno Tranquezi Cordeiro et al.
Alzheimer s & Dementia
Telomeres, Telomerase, and Senescence
article

Wnt/pathway, APP processing and telomere shortening in Down syndrome adults

Jessyka Maria de França Bram, Orestes Vicente Forlenza, Leda Leme Talib, Augusto Magno Tranquezi Cordeiro, Lillian Caroline Fernandes
article en

Abstract

Abstract Background The Down Syndrome (DS), also referred to as trisomy of chromosome 21, is a prevalent cause of intellectual disability and also contributes to the acceleration of aging, among other developmental and health concerns. Certain pathological characteristics shared by DS and Alzheimer’s Disease (AD) indicate similar commonalities. This study aims to unravel the relationship between the canonical Wnt/pathway, the amyloid precursor protein processing, the telomere shortening in DS individuals. The telomere is a structure found at the end of the chromosomes that protects against degradation during cell division. The shortening of the telomere length is associated with the risk of AD. β‐catenin is an important factor in the canonical Wnt pathway. The activation of this pathway can protect against neurotoxic effects caused by accumulation of β‐amyloid peptide and the phosphorylation of Tau protein. The canonical Wnt activation is related with the activation of subunit Tert, also known as telomerase. Telomerase is an enzyme responsible for the maintenance of telomere length. Methods The biomarkers were quantified in the plasma and platelets of adults and elderly with DS (n = 55) and adults and elderly without DS (n = 80). We utilized western blot, for APP fragments (110 kDa and 130 kDa), Luminex xMAP, for AB40 fragment. The DNA was extracted from leukocytes and measured using qPCR method using 36B4 as single copy gene. Telomere length was calculated using the delta Ct value. Results We found increased levels of Aβ40 and in 110 kDa, 130 kDa APP fragments of Down syndrome individuals. β‐catenin was also increased in DS group when compared with non DS group. The telomere length was decrease in DS group when compared with non DS group. Conclusion The increase in Aβ40 and 110 kDa, 130 kDa fragments, demonstrated an imbalance in the APP processing, that could lead to the Aβ aggregation observed in DS individuals. The increase in the β‐catenin expression could be a compensatory mechanism for the telomere shortening in DS group.

Alzheimer s & DementiaVol. 20(S2)
Universidade de São Paulo (BR), Hospital Universitário da Universidade de São Paulo (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Openalex Percentile: Top 65%
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.